Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture [Studio multicentrico, internazionale, randomizzato in doppio cieco per valutare gli effetti di 4 mesi di somministrazione orale di 2 g al giorno di ranelato di stronzio verso placebo sulla qualita' dell'osso e sul rimodellamento dell'osso alveolare, valutato tramite biopsia estratta prima di un impianto dentario, in pazienti con osteoporosi o a rischio di frattura osteoporotica]

Next Previous
X
Search
Trial Profile

A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture [Studio multicentrico, internazionale, randomizzato in doppio cieco per valutare gli effetti di 4 mesi di somministrazione orale di 2 g al giorno di ranelato di stronzio verso placebo sulla qualita' dell'osso e sul rimodellamento dell'osso alveolare, valutato tramite biopsia estratta prima di un impianto dentario, in pazienti con osteoporosi o a rischio di frattura osteoporotica]

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Jul 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Strontium ranelate (Primary)
  • Indications Fracture
  • Focus Therapeutic Use
  • Sponsors Servier

    • Most Recent Events

    • 24 May 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 03 Apr 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top